ScoreWhy is Amrutanjan Health Care Ltd ?
1
High Management Efficiency with a high ROE of 19.83%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 9.01% and Operating profit at 7.01% over the last 5 years
4
Positive results in Dec 24
- PAT(HY) At Rs 31.05 cr has Grown at 27.78%
- PBDIT(Q) Highest at Rs 23.34 cr.
- OPERATING PROFIT TO NET SALES(Q) Highest at 19.01%
5
Stock is technically in a Mildly Bearish range
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
6
With ROE of 16.6, it has a Attractive valuation with a 6.2 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -5.09%, its profits have risen by 12.1% ; the PEG ratio of the company is 2.8
7
Majority shareholders : Promoters
8
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -5.09% returns in the last 1 year, the stock has also underperformed BSE 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Amrutanjan Healt should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Drugs should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Amrutanjan Healt for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Amrutanjan Healt
-5.31%
-0.14
36.78%
SENSEX
0.45%
0.03
14.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.01%
EBIT Growth (5y)
7.01%
EBIT to Interest (avg)
55.07
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.52
Tax Ratio
27.34%
Dividend Payout Ratio
29.57%
Pledged Shares
0
Institutional Holding
13.42%
ROCE (avg)
39.74%
ROE (avg)
19.83%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
37
Industry P/E
33
Price to Book Value
6.15
EV to EBIT
35.01
EV to EBITDA
31.04
EV to Capital Employed
7.77
EV to Sales
3.97
PEG Ratio
2.79
Dividend Yield
0.73%
ROCE (Latest)
21.46%
ROE (Latest)
16.57%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
PAT(HY)
At Rs 31.05 cr has Grown at 27.78%
PBDIT(Q)
Highest at Rs 23.34 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 19.01%
PBT LESS OI(Q)
Highest at Rs 21.63 cr.
EPS(Q)
Highest at Rs 6.66
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Amrutanjan Healt
Operating Profit (PBDIT) - Quarterly
Highest at Rs 23.34 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 19.01%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 21.63 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 19.25 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 6.66
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
